Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

D Zhou, HME Duyvesteyn, CP Chen… - Nature structural & …, 2020 - nature.com
… We set out to characterize the antibody response in individuals infected with SARS-CoV-2.
One antibody, EY6A, identified from a convalescent patient was found to recognize the RBD …

[HTML][HTML] Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance

B Freeman, S Lester, L Mills, MAU Rasheed, S Moye… - Biorxiv, 2020 - ncbi.nlm.nih.gov
… and validation of a SARS-CoV-2 spike protein ELISA. We … who had a SARS-CoV-2 infection
without prior molecular … with convalescent sera collected from two COVID-19 patients at days …

[HTML][HTML] Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

S Shoham, EM Bloch, A Casadevall, D Hanley, B Lau… - medRxiv, 2021 - ncbi.nlm.nih.gov
COVID-19. In this sample of outpatients exposed to COVID-19, CCP did not reduce SARS-CoV-2
infection in … in hospitalized patients 32 and do not rule out the possibility of ADE in early …

Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

C Feng, J Shi, Q Fan, Y Wang, H Huang, F Chen… - Nature …, 2021 - nature.com
… against COVID-19 in persons aged >16 years 4 . SARS-CoV-2 convalescent patients and
… Protective immune responses against SARS-CoV-2 infection consists of two main parts, …

[HTML][HTML] Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects

A Manenti, E Gianchecchi, F Dapporto… - Journal of …, 2022 - Elsevier
… , whereas convalescent patients presented high levels of … SARS-CoV-2 variants. Due to the
objective difficulties to have, especially for the convalescent group, the exact time of infection

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

EHY Lau, DSC Hui, OTY Tsang, WH Chan… - …, 2021 - thelancet.com
… the mean level of antibody found in COVID-19 convalescent sera [ … convalescent sera.
Using this approach, we estimate that 50% of patients who recover from symptomatic SARS-CoV

[HTML][HTML] SARS-CoV-2 Omicron variant: recent progress and future perspectives

Y Fan, X Li, L Zhang, S Wan, L Zhang… - Signal transduction and …, 2022 - nature.com
… Moreover, individuals previously infected with other SARS-CoV-2 variants can be reinfected
with … Moreover, a recent study showed that BA.2 can re-infect BA.1 convalescent patients, …

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma

K Maeda, N Higashi-Kuwata, N Kinoshita, S Kutsuna… - Scientific Reports, 2021 - nature.com
… due to SARS-CoV-2 infection. Thereby, … COVID-19-convalescent patients. It is known that
serum levels of IgM and IgA that bind to SARS-CoV-2 virions also increase after viral infection

… -II clinical trial with or without infusion of plasma from subjects after convalescence of SARS-CoV-2 infection in high-risk patients with confirmed severe SARS-CoV-2 …

M Janssen, U Schäkel, C Djuka Fokou, J Krisam… - Trials, 2020 - Springer
… as two points on … patients (group 1 to group 4) with SARS-CoV-2 infection requiring hospital
admission by infusion of plasma from subjects after convalescence of SARS-CoV-2 infection

D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

J Hu, CL He, QZ Gao, GJ Zhang, XX Cao, QX Long… - BioRxiv, 2020 - biorxiv.org
convalescent patients with COVID-19 against SARS-CoV-2 S-… of sera from convalescent
COVID-19 patients was analyzed … from some patients infected with earlier SARS-CoV-2 variant. …